Xenon Pharmaceuticals (XENE) Interest Expenses (2013 - 2020)
Xenon Pharmaceuticals (XENE) reported Interest Expenses of $154000.0 for Q2 2020, down 57.81% year-over-year from $365000.0 in Q3 2019, and down 53.33% quarter-over-quarter from $330000.0 in Q1 2020.
Xenon Pharmaceuticals (XENE) Interest Expenses (2013 - 2020) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 4 years of Interest Expenses data on file, last reported at $154000.0 in Q2 2020.
- Interest Expenses for Q2 2020 came in at $154000.0, down 57.81% year-over-year; the trailing twelve-month figure through Mar 2021 was $154000.0 (down 89.05% YoY), and the FY2020 annual result was $484000.0, down 66.25% from the prior year.
- Interest Expenses retreated to $154000.0 in Q2 2020 per XENE's latest filing, from $330000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $678000.0 in Q3 2018 and troughed at $154000.0 in Q2 2020.
- A 3-year average of $331200.0 and a median of $352500.0 in 2018 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2019 and 2020: Interest Expenses surged 125.16% in 2019, then sank 57.81% in 2020.
- A 3-year view of Interest Expenses shows it stood at $357000.0 in 2018, then declined by 2.52% to $348000.0 in 2019, then sank by 55.75% to $154000.0 in 2020.
- Business Quant data shows XENE's Interest Expenses at $154000.0 in Q2 2020, $330000.0 in Q1 2020, and $348000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Xenon Pharmaceuticals | 4.61 Bn | 4.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 154,000.00 |
| Jun 30, 2020 | 154,000.00 |
| Mar 31, 2020 | 330,000.00 |
| Mar 31, 2020 | 330,000.00 |
| Dec 31, 2019 | 348,000.00 |
| Dec 31, 2019 | 348,000.00 |
| Sep 30, 2019 | 363,000.00 |
| Sep 30, 2019 | 363,000.00 |
| Jun 30, 2019 | 365,000.00 |
| Jun 30, 2019 | 365,000.00 |
| Mar 31, 2019 | 358,000.00 |
| Mar 31, 2019 | 358,000.00 |
| Dec 31, 2018 | 357,000.00 |
| Dec 31, 2018 | 357,000.00 |
| Sep 30, 2018 | 678,000.00 |
| Sep 30, 2018 | 678,000.00 |
| Jun 30, 2018 | 200,000.00 |
| Jun 30, 2018 | 200,000.00 |
| Mar 31, 2018 | 159,000.00 |
| Mar 31, 2018 | 159,000.00 |